Essais liés11clinical trials
VilleBadalonalocalisation
PaysSpainlocalisation
SourcelocaleCSV/MySQL

Informations

centre

Synchronisé depuis ClinicalTrials.gov — NCT07227246

Ouvrir le site du centre

Essais cliniques associés

11
MoléculeIndication / populationPhaseNCTTitreStatut
Hearo App Insuffisance cardiaque À vérifier NCT06378632 DETECT-HF — AN INTERNATIONAL, OBSERVATIONAL, BLINDED STUDY TO ASSESS THE PERFORMANCE OF THE CORDIO HEARO SYSTEM COMPLETED
BIA 28-6156 10 mg Parkinson Phase 2 NCT05819359 ACTIVATE — Efficacy, Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of BIA 28-6156 in GBA-PD COMPLETED
Pleneva TM BGC20-0134 SEP Phase 2 NCT01037907 A Study of Orally Administered BGC20-0134 (Structured Lipid) in Patients With Relapsing Remitting Multiple Sclerosis (RRMS) TERMINATED
Maridebart cafraglutide Insuffisance cardiaque Phase 3 NCT07037459 MARITIME-HF — Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity RECRUITING
Selatogrel Maladie coronarienne Phase 3 NCT04957719 SOS-AMI — Selatogrel Outcome Study in Suspected Acute Myocardial Infarction ENROLLING_BY_INVITATION
SELUTION SLRTM sirolimus coated balloon Maladie coronarienne À vérifier NCT07256249 Real-life Registry in Patients With Coronary Artery Disease Treated With the SELUTION Sirolimus-eluting Balloon. Selution Iberia Registry RECRUITING
RapidPulseTM Aspiration System Accident vasculaire cérébral Non applicable NCT06029491 TURBO — Thrombectomy Using Pulsed Aspiration for Reperfusion of Brain Occlusions RECRUITING
Recombinant Factor VIIa Accident vasculaire cérébral Phase 3 NCT07227246 FASTEST Part 2 — Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2 RECRUITING
ITI-1284 Alzheimer Phase 2 NCT06651567 A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Agitation Associated With Alzheimer's Dementia RECRUITING
Litifilimab Lupus Phase 2/3 NCT05531565 AMETHYST — A 2-Part Study to Learn Whether Litifilimab (BIIB059) Injections Can Improve Symptoms of Adult Participants Who Have Active Cutaneous Lupus Erythematosus ACTIVE_NOT_RECRUITING
BIA 28-6156 Parkinson À vérifier NCT07522606 Compassionate Use for BIA 28-6156 in Patients With Parkinson's Disease (PD) Who Have a Pathogenic Variant in the GBA1 Gene (GBA-PD) and Completed the ACTIVATE Study NO_LONGER_AVAILABLE